GMD is a leading Canadian supply chain service provider to the Life Sciences Industry. Established in 2003, the Company develops customized programs for its domestic and international customers that enable direct distribution of pharmaceuticals and other products to pharmacies, clinics, patient homes and offices.
NewPoint was retained by the shareholders of GMD to explore a potential divestiture. NewPoint assisted the client with all aspects relevant to the transaction including sourcing and approaching a broad list of financial buyers, negotiating the key transaction terms including the purchase price, due diligence and all agreements related to closing.
After approaching a variety of North American private equity firms and alternate financing sources, NewPoint identified a structure that maximized liquidity, while allowing key management to retain a meaningful ownership interest in the business going forward.